By Benjamin Chiou
Date: Wednesday 04 Nov 2026
(Sharecast News) - Medical technology group Smith & Nephew cut its full-year revenue and profit forecasts on Wednesday as weakness in its US hip and knee implant businesses continued to weigh on performance, despite an acceleration in third-quarter sales growth.
| Director/PDMR Shareholding | 11-Nov-2026 | 15:18 | RNS |
| Share Buyback Programme | 11-Nov-2026 | 07:30 | RNS |
| Smith+Nephew Third Quarter 2026 Trading Update | 04-Nov-2026 | 07:00 | RNS |
| Total Voting Rights | 02-Nov-2026 | 12:12 | RNS |
| Sterling Amount of Dividend | 22-Oct-2026 | 10:25 | RNS |
| Biz Briefing: Bank Rate And Drink Figures | 10-Feb-2011 | Sky News |
| FTSE live: Diageo falls, S&N up, rates decision | 10-Feb-2011 | Daily Mail |
| FTSE Close: Lonmin, BHP up; Rolls-Royce down | 16-Nov-2010 | Daily Mail |
| FTSE live: BAE down; Smith & Nephew up Read mor... | 20-Oct-2010 | Daily Mail |
| FTSE close: C&W down, BP and the index up | 07-Sep-2010 | Daily Mail |
| Currency | UK Pounds |
| Share Price | 1,176.50p |
| Change Today | 7.00p |
| % Change | 0.60 % |
| 52 Week High | 1,371.50 |
| 52 Week Low | 982.40 |
| Volume | 2,745,390 |
| Shares Issued | 837.43m |
| Market Cap | £9,852m |
| RiskGrade | 173 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 2 |
| Buy | 1 |
| Neutral | 11 |
| Sell | 2 |
| Strong Sell | 0 |
| Total | 16 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 01-Oct-26 | 26-Mar-26 |
| Paid | 06-Nov-26 | 27-May-26 |
| Amount | 15.60¢ | 24.10¢ |
| Time | Volume / Share Price |
| 16:35 | 1,218,985 @ 1,176.50p |
| 16:35 | 3,703 @ 1,176.50p |
| 16:35 | 2,835 @ 1,176.50p |
| 16:35 | 600 @ 1,176.50p |
| 16:35 | 600 @ 1,176.50p |
You are here: research